Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/1999
10/19/1999US5969117 Modified protein kinase a-specific oligonucleotide
10/19/1999US5969110 Antibodies which are immunoreactive with a human tyrosine kinase ligand protein
10/19/1999US5969109 Chimeric antibodies comprising antigen binding sites and B and T cell epitopes
10/19/1999US5969107 Monoclonal antibody containing antigen recognition sites which mimic antigenic regions of receptors; diagnostic and therapeutic tool for treatment of tumors
10/19/1999US5969106 Self-aligning peptides modeled on human elastin and other fibrous proteins
10/19/1999US5969105 Stem cell factor receptor agonists
10/19/1999US5969104 Amino acid sequence of cell surface receptor expressed on macrophages; for antitumor agents and treatment of graft rejection and infections
10/19/1999US5969103 Cocaine and amphetamie regulated transcript protein; for diagnosis, therapy
10/19/1999US5969102 Lymphocyte surface receptor that binds CAML, nucleic acids encoding the same and methods of use thereof
10/19/1999US5969100 Peptide, peptide analog and amino acid analog protease inhibitors
10/19/1999US5969099 Growth factor analogs
10/19/1999US5969098 Polypeptide which is microbicide, fungicide, bactericide, antiprotozoa agents
10/19/1999US5969096 Conotoxin peptides
10/19/1999US5969095 Analogs of parathyroid hormone
10/19/1999US5969094 Anti-paramyxovirus screening method and vaccine
10/19/1999US5969093 Secreted proteins
10/19/1999US5969040 Factor IX -- polymeric conjugates
10/19/1999US5968989 Administering pharmaceutical composition comprising a compound more potent as a modulator for retinoid x receptor (rxr) in a cotransfection assay than is all-trans-retinoic acid, and a carrier; skin disorders
10/19/1999US5968988 Methods of using Ajoene for treatment of shock
10/19/1999US5968983 Administering a mixture of arginine and an inhibitor of a reductase
10/19/1999US5968972 Administering a cyclosporin and paclitaxel or salt
10/19/1999US5968970 Treatment of hiv
10/19/1999US5968966 Non-oral administering of composition containing l-carnosine
10/19/1999US5968942 Inhibitors of hiv protease
10/19/1999US5968932 Method of inhibiting sleep apnea
10/19/1999US5968927 Azepino-indole compounds; treatment of inflammatory, autoimmune and neurodegenerative diseases, prevention of ischemic injury
10/19/1999US5968924 Benzo-fused lactams promote release of growth hormone
10/19/1999US5968921 Compositions and methods for promoting nerve regeneration
10/19/1999US5968905 Administering cholinergic differentiation factor/leukemia inhibitory factor to adrenal medullary chromaffin cells or to injured nerves
10/19/1999US5968904 Modified arginine containing lytic peptides and method of making the same by glyoxylation
10/19/1999US5968903 Helicobacter and antigrowth agents, using somatostatin or agonist
10/19/1999US5968902 Platelet aggregation inhibitors
10/19/1999US5968900 Increasing blood plasma concentrations and muscle storage by administering mixtures of creatine and carbohydrates, also a simultaneous increase in blood insulin concentration
10/19/1999US5968899 Medicinal compositions of peptides with EACA or tranexamic acid for enhanced mucosal absorption
10/19/1999US5968898 THF-γ2 analogs and pharmaceutical compositions comprising them
10/19/1999US5968897 Cardiovascular disorders and blood factors
10/19/1999US5968896 Nutritional supplement for preoperative feeding
10/19/1999US5968895 Solid ionic complexes of luteinizing hormone releasing hormone analogues(active peptides) and anionic polymer carriers, also for stable suspensions or dispersions(not microencapsulated), for treatment of prostate cancer
10/19/1999US5968894 Verotoxin pharmaceutical compositions and medical treatments therewith
10/19/1999US5968838 Antiarrhythmic peptide from venom of spider Grammostola spatulata
10/19/1999US5968826 Antisense inhibition of integrin α4 expression
10/19/1999US5968825 Antisense oligonucleotides complementary to the primary transcript of the human c-fes protooncogene
10/19/1999US5968824 Administering agent which modulates biochemical pathway in which products of opioid peptide precursor genes participate; antitumor agents; prevention of opacity of intraocular lens after cataract surgery
10/19/1999US5968823 Bird cells genetically engineered with exogenous nucleic acid coding mammalian transport protein; screening for compounds to treat brain disorders; alzheimer's/huntington's/ parkinson's diseases
10/19/1999US5968822 Polynucleotide encoding a polypeptide having heparanase activity and expression of same in transduced cells
10/19/1999US5968819 DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5)
10/19/1999US5968818 Nucleic acid coding an enzyme whose presence can be used to acess sensitivity to atherosclerosis
10/19/1999US5968809 Methods and compositions for synthesis of long chain poly-unsaturated fatty acids
10/19/1999US5968803 Human DNA topoisomerase I α
10/19/1999US5968798 Polynucleotide coding for polypeptide important in dna synthesis and cell division; for diagnosis, prevention and treatment of immunological disorders, autoimmune disorders, tumors, cancer; anticarcinogenic/antitumor agents
10/19/1999US5968797 Diagnostic and therapeutic tool in treatment of alzheimers disease, atrophying skeletal muscle, swine fever virus and apoptosis; anticarcinogenic/antitumor agents
10/19/1999US5968780 Dendritic cell-derived growth factor
10/19/1999US5968779 Recombinant obese (ob) proteins
10/19/1999US5968777 DNA encoding seryl t-RNA synthetase
10/19/1999US5968770 Compositions and methods for the treatment and diagnosis of cardiovascular disease using rchd523 as a target
10/19/1999US5968768 CD6 ligand encoding sequence
10/19/1999US5968764 Detecting modulators of glucose transport protein; therapy for diabetes and disorders of insulin resistance, by incubating glucose transport protein with test compound, adding transport protein substrate, monitoring effect
10/19/1999US5968754 Detecting the presence of breast cancer proteins in humans; screening for breast cancer by measuring diagnostic marker for breast cancer in sample
10/19/1999US5968752 Method for identifying an OP-1 analog which binds an ALK-1 receptor
10/19/1999US5968751 Immunoassay to detect antigen using antibodies against binding domain sequence of a serine protease
10/19/1999US5968749 Acyl coenzyme A : cholesterol acyltransferase (ACAT)
10/19/1999US5968748 Antisense oligonucleotide modulation of human HER-2 expression
10/19/1999US5968747 Polynucleotide encoding polypeptide; therapy for prevention and treatment of cancer, autoimmune diseases, developmental defects, nervous system disorders
10/19/1999US5968744 Human cornichon molecule
10/19/1999US5968742 Polynucleotide which codes glycosyl-phosphatidyl inositol anchor; for diagnosis and prevention of fungal and parasitic infections; parasitides; fungicides;
10/19/1999US5968737 Method of identifying inhibitors of glutathione S-transferase (GST) gene expression
10/19/1999US5968734 Dna sequences that migrate to new genetic positions and the fusion products; diagnosis of carcinomas, melanomas, and sarcomas suchas ewing's sarcoma
10/19/1999US5968527 Exposure to varying electric, magnetic, or radiating electromagnetic field to treat ischemia, hypoxia, and/or anoxia
10/19/1999US5968526 Mixing blood sample with peptide isolated from dust mite allergen protein to determine amount of binding which will indicate degree of sensitivity
10/19/1999US5968524 Methods and compounds for the treatment of immunologically-mediated psoriasis
10/19/1999US5968522 Dna and antibiodies directed against polypeptides
10/19/1999US5968514 Polypeptides and proteins for immunology
10/19/1999US5968513 Administering cyclic peptide; gene therapy; autoimmune diseases; anticarcinogenic agents
10/19/1999US5968512 Antibody recognizing endothelial cell ligand for leukocyte CR3
10/19/1999US5968510 CTLA4 receptor and uses thereof
10/19/1999US5968509 Antibodies with binding affinity for the CD3 antigen
10/19/1999US5968507 Method for removing nits from hair
10/19/1999US5968502 Genetic engineering of proteins in cells
10/19/1999US5968501 Genetically engineering, transformation
10/19/1999US5968253 Calcium phosphate cements comprising antimicrobial agents
10/19/1999CA1340796C Antisense oligonucleotide antibiotics complementary to the macromolecular synthesis operon, methods of treating bacterial infections, and methods for identification of bacteria
10/14/1999WO1999051779A2 Glaucoma therapeutics and diagnostics
10/14/1999WO1999051762A1 Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders
10/14/1999WO1999051751A1 Hiv cofactor inhibitors and medicinal compositions for preventing or treating hiv-infection
10/14/1999WO1999051748A2 Fusion proteins of mycobacterium tuberculosis antigens and their uses
10/14/1999WO1999051744A2 A interleukin-1 receptor antagonist and uses thereof
10/14/1999WO1999051742A2 Dadd, death activator death domain protein
10/14/1999WO1999051741A2 Lyst protein complexes and lyst interacting proteins
10/14/1999WO1999051740A2 Nucleotide sequence expressing human fatty acid transport protein and corresponding aminoacid, use for the regulation of fatty acids metabolism
10/14/1999WO1999051739A1 Protein variant of the net1 locus
10/14/1999WO1999051738A1 Human gap junction protein beta-4
10/14/1999WO1999051737A1 Highly active forms of interferon regulatory factor proteins
10/14/1999WO1999051736A1 Neuron regulatory factor comprising a small peptide for promoting neuron survival
10/14/1999WO1999051735A2 Mapkap kinase 2-inhibitors and the use thereof in anti-inflammatory therapy
10/14/1999WO1999051732A1 Secreted proteins and polynucleotides encoding them
10/14/1999WO1999051730A2 Mammalian gene encoding tolloid-like protein
10/14/1999WO1999051727A2 Human nucleic acid sequences of normal ovary tissue
10/14/1999WO1999051720A2 Methods for production of therapeutic cytokines
10/14/1999WO1999051643A1 Mutagenized il13-based chimeric molecules
10/14/1999WO1999051642A1 Antibody variants and fragments thereof
1 ... 2466 2467 2468 2469 2470 2471 2472 2473 2474 2475 2476 2477 2478 2479 2480 2481 2482 2483 2484 2485 2486 ... 3163